Celgene to Acquire Quanticel Pharmaceuticals

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. META
6. TSLA
7. SMCI
8. RTX
9. S
10. COF

Go back to Celgene to Acquire Quanticel Pharmaceuticals

Celgene (CELG) to Acquire Quanticel Pharma in $485M Deal

April 27, 2015 7:31 AM EDT

Celgene (NASDAQ: CELG) and Quanticel Pharmaceuticals, Inc., a privately held biotechnology company focused on cancer drug discovery, today announced a definitive share purchase agreement under which Celgene Corporation will acquire Quanticel. Through the agreement, Celgene will have full access to Quanticels proprietary platform for the single-cell genomic analysis of human cancer, as well as Quanticels lead programs that target specific epigenetic modifiers to advance Celgenes pipeline of innovative cancer therapies.

The acquisition culminates a 2011 strategic alliance between Celgene and Quanticel. Over the course of the three-and-a-half year alliance,... More